Exchange: NASDAQ·Updated 04:10 PM EST

COAG Hemab Therapeutics Holdings Inc.

$39.29
$0.57
(1.43%)
Today
Closed $39.29
$0.00
(0.00%)
After Hours
Reported EarningsNov 10
Mkt Cap$1.86B
Vol347,015.00

About COAG

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded in 2020 and is headquartered in Cambridge, MA.
51

Neutral Sentiment

How do you feel about COAG?

Advertisement|Remove ads.